Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Clinical trial NCT02620423 · COMPLETED
Trial details
- NCT number
- NCT02620423
- Sponsor
- Oncolytics Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.